Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
FORXIGA™ (dapagliflozin) now approved in European Union for treatment of type 2 diabetes
-
Court in Germany finds SEROQUEL XR® formulation patent invalid
-
Definition of Core Financial Measures
-
AstraZeneca announces top-line phase III results from naloxegol pivotal trials in patients with opioid-induced constipation
-
Alzheimer’s, cancer and rare disease research to benefit from landmark MRC-AstraZeneca compound collaboration
-
AstraZeneca announces details of Chief Executive Officer Pascal Soriot's remuneration
-
AstraZeneca PLC Third quarter and nine months results 2012
-
AstraZeneca and Ironwood announce linaclotide collaboration for China
-
AstraZeneca and Ardelyx announce worldwide licensing deal for NHE3 inhibitor programme for complications of renal disease, including diabetes-induced renal disease
-
AstraZeneca suspends share repurchase programme, Core EPS target in the range of $6.00 and $6.30 unchanged
Latest articles and press releases
All of our latest press releases and articles are available to explore
